Prevalence of Pre-existing Antibodies to CRISPR-associated Nuclease Cas9 in the US Population

Posted by Shopify API on

Single Donor Human Serum from Innovative Research was recently used in the following study:

Prevalence of Pre-existing Antibodies to CRISPR-associated Nuclease Cas9 in the US Population

Simhadri VL, McGill J, McMahon S, Wang J, Jiang H, Sauna ZE
Molecular Therapy: Methods & Clinical Development (2018)

... Serum samples from healthy donors were purchased from Innovative Research (Innovative Research, Novi, MI) and stored at -80oC until analysis. SaCas9 and SpCas9 proteins were custom-produced ...

Related products available from Innovative Research also include:

  • Tags: Human Serum, Single Donor Human Serum Off The Clot

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Innovative Research’s Role in Developing a Zero-Gravity Versatile Sample Preparation Platform (VSPP)
    The realm of space exploration continually seeks innovations that can enhance the safet...
    Read the Article
    We have biological products and research materials to assist with early phase next gen COVID vaccine research
    This autumn, as clinical trials get underway to evaluate the effectiveness of the most ...
    Read the Article
    Monoclonal Antibody to VLDLR (MA-1H10): An Explainer
    The Innovative Research lab pulled together an explainer on one of our recently popular...
    Read the Article

    ← Older Post Newer Post →

    ×